Literature DB >> 3930267

Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium.

P D'Orléans-Juste, S Dion, J Mizrahi, D Regoli.   

Abstract

Peptides and non-peptides acting as vasoconstrictors or vasodilators have been tested in dog isolated carotid arteries with and without endothelium and in the presence and absence of a variety of antagonists and inhibitors of endogenous substances. It has been found that substance P and several other tachykinins, bradykinin, neurotensin, bombesin and acetylcholine relax the isolated artery only when the endothelium is present, while VIP, isopropylnoradrenaline, adenosine, histamine, prostaglandins E1 and E2, glucagon and insulin relax and angiotensin, vasopressin, oxytocin, 5-HT and noradrenaline contract the isolated vessel, no matter whether the endothelium is present or not. Peptide and non-peptide antagonists have been used with success to show that vasoconstrictors and vasodilators act on specific receptors, since their effects are reduced in the presence of antagonists, specific for one or another of the various agents. Inhibitors of the arachidonic acid cascade only reduce the effect of acetylcholine, suggesting that at least two different mechanisms are involved in the endothelium-mediated relaxation of arterial smooth muscles to peptide and non-peptide agents. The results summarised in this paper suggest that the site of action of several vasodilators is the endothelium, while other vasodilators and all the vasoconstrictors influence the arterial vessels tone presumably by acting on the smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930267     DOI: 10.1016/0014-2999(85)90515-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  33 in total

1.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  The role of bradykinin in the regulation of blood flow to hindlimb muscle groups of the anaesthetized cat.

Authors:  S M Poucher; S Garcia; R Brooks
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

4.  Gastric vasodilatation and vasoactive intestinal peptide output in response to vagal stimulation in the dog.

Authors:  S Ito; A Ohga; T Ohta
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

5.  Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.

Authors:  J W Constantine; W S Lebel; H A Woody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

6.  Local formation of angiotensin II in the rat aorta: effect of endothelium.

Authors:  C Eglème; F Cressier; J M Wood
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

7.  Endothelium-derived relaxing factor (EDRF) and resistance vessels in an intact vascular bed: a microangiographic study of the rabbit isolated ear.

Authors:  T M Griffith; D H Edwards; R L Davies; T J Harrison; K T Evans
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

8.  Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.

Authors:  A Roccon; D Marchionni; D Nisato
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  The action of Hoe 140 on the bradykinin-induced splenic pressor reflex of the anaesthetized cat.

Authors:  J B Louttit; R A Coleman
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 10.  Endothelium-derived relaxing factor and the pulmonary circulation.

Authors:  G Cremona; A T Dinh Xuan; T W Higenbottam
Journal:  Lung       Date:  1991       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.